Influence of an alkalizing supplement on markers of endurance performance using a double-blind placebo-controlled design

Table 4 Summary heart rate (BPM) measures resulting from five upper body power tests

Group	Test Period	Constant Power Test	UBP10 Test Trial #1	UBP10 Test Trial #2	UBP10 Test Trial #3	UBP60 Test
Placebo (n = 12)	Pre-Test	161 ± 4	156 ± 2	167 ± 2	169 ± 2	182 ± 2
	Post-Test	160 ± 4	157 ± 3	167 ± 3	169 ± 3	183 ± 2
Treatment (n = 12)	Pre-Test	164 ± 6	158 ± 5	165 ± 4	166 ± 4	184 ± 4
	Post-Test	†159 ± 6	160 ± 6	169 ± 6	167 ± 4	†177 ± 3

NOTE: All values expressed as Mean ± SE; UBP10 = 10-sec upper body power test; UBP60 = 60-sec upper body power test
†Post-test measure of heart rate for Constant-Power and UBP60 tests were significantly lower than pre-test measure within the treatment group (P < 0.05)

ISSN: 1550-2783